ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 916,09
1,63%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Intelgenx Technologies Corp (IGX)

  7. Intelgenx Technologies Corp (IGX) Actualités

IGX

Intelgenx Technologies (IGX)

Intelgenx Technologies Corp
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:IGX
DateHeureSourceTitreSymboleSociété
27/03/202016h54PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202016h52PR Newswire (Canada)IIROC Trading Resumption - IGXTSXV:IGXIntelgenx Technologies Corp
27/03/202015h04PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - Enter Symbol(s) HereTSXV:IGXIntelgenx Technologies Corp
27/03/202015h02PR Newswire (Canada)IIROC Trading Halt - IGXTSXV:IGXIntelgenx Technologies Corp
19/12/201922h32PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGXTSXV:IGXIntelgenx Technologies Corp
18/10/201816h08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX ; IGX.DBTSXV:IGXIntelgenx Technologies Corp
18/10/201816h07PR Newswire (Canada)IIROC Trading Resumption - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201822h31PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
17/10/201822h28PR Newswire (Canada)IIROC Trading Halt - IGX, IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715h53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - IGX; IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715h27PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
05/12/201715h24PR Newswire (Canada)IIROC Trading Halt - IGX IGX.DBTSXV:IGXIntelgenx Technologies Corp
15/11/201114h16MarketwiredSpeculative Healthcare Companies IntelGenx and Adventrx Begin to Gain GroundTSXV:IGXIntelgenx Technologies Corp
09/08/201112h00MarketwiredIntelGenx Reports Q2, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
02/08/201112h00MarketwiredIntelGenx Announces Successful Pre-Approval Inspection of its Lead Product CPI-300TSXV:IGXIntelgenx Technologies Corp
22/06/201116h35MarketwiredIntelGenx Announces Closing of Private PlacementsTSXV:IGXIntelgenx Technologies Corp
14/06/201118h36MarketwiredIntelGenx Announces Licensing of Anti-Psychotic VersaFilm ProductTSXV:IGXIntelgenx Technologies Corp
14/06/201112h00MarketwiredIntelGenx Announces New PDUFA Date for Its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
03/06/201115h45MarketwiredIntelGenx Announces Up to Approximately US$3 Million Equity Offering of Common Stock and WarrantsTSXV:IGXIntelgenx Technologies Corp
24/05/201112h00MarketwiredIntelGenx Welcomes Dr. Rajiv Khosla to Its BoardTSXV:IGXIntelgenx Technologies Corp
16/05/201112h00MarketwiredIntelGenx Submits Reply to FDA Complete Response Letter for its Single Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
11/05/201112h00MarketwiredIntelGenx Reports Q1, 2011 Results and Highlights Recent DevelopmentsTSXV:IGXIntelgenx Technologies Corp
06/04/201112h00MarketwiredIntelGenx Completes Positive Bioequivalence Study with Insomnia Thin FilmTSXV:IGXIntelgenx Technologies Corp
30/03/201112h00MarketwiredIntelGenx Reports 2010 Financial Results and Summarizes Key DevelopmentsTSXV:IGXIntelgenx Technologies Corp
04/03/201120h36MarketwiredIntelGenx Announces Departure of DirectorTSXV:IGXIntelgenx Technologies Corp
07/02/201112h00MarketwiredIntelGenx Achieves Positive Bioequivalence Results for a Leading Branded Anti-Psychotic Using VersaFilm Oral Thin Film TechnologTSXV:IGXIntelgenx Technologies Corp
03/02/201112h00MarketwiredIntelGenx Announces Dismissal of Patent Litigation Relating to Its Once Daily High Dose 450 mg Bupropion Hydrochloride TabletTSXV:IGXIntelgenx Technologies Corp
05/01/201112h00MarketwiredIntelGenx to Present at OneMedForum Conference in San FranciscoTSXV:IGXIntelgenx Technologies Corp
04/01/201112h00MarketwiredIntelGenx Receives Positive Ruling in Patent Litigation HearingTSXV:IGXIntelgenx Technologies Corp
29/11/201012h00MarketwiredIntelGenx Acquires Full Ownership and Exclusive Rights to MS Induced Pain ProductTSXV:IGXIntelgenx Technologies Corp
 Showing the most relevant articles for your search:TSXV:IGX

Dernières Valeurs Consultées

EU
ML
Michelin
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
EU
PX4
SBF 120
NYSE
DIS
Walt Disney
EU
RNO
Renault
EU
CS
Axa
EU
BN
Danone
EU
LR
Legrand
NASDAQ
AMZN
Amazon.com
EU
AF
Air FranceKLM
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés